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Neurobiology of Disease

Opposing Brain Differences in 16p11.2 Deletion and
Duplication Carriers
Abid Y. Qureshi,1,2 Sophia Mueller,4,5 Abraham Z. Snyder,6 Pratik Mukherjee,7 Jeffrey I. Berman,9
Timothy P.L. Roberts,9 Srikantan S. Nagarajan,7 John E. Spiro,10 Wendy K. Chung,11 Elliott H. Sherr,8
and Randy L. Buckner1,3,4 on behalf of the Simons VIP Consortium
1
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Deletions and duplications of the recurrent ⬃600 kb chromosomal BP4 –BP5 region of 16p11.2 are associated with a broad variety of
neurodevelopmental outcomes including autism spectrum disorder. A clue to the pathogenesis of the copy number variant (CNV)’s effect
on the brain is that the deletion is associated with a head size increase, whereas the duplication is associated with a decrease. Here we
analyzed brain structure in a clinically ascertained group of human deletion (N ⫽ 25) and duplication (N ⫽ 17) carriers from the Simons
Variation in Individuals Project compared with age-matched controls (N ⫽ 29 and 33, respectively). Multiple brain measures showed
increased size in deletion carriers and reduced size in duplication carriers. The effects spanned global measures of intracranial volume,
brain size, compartmental measures of gray matter and white matter, subcortical structures, and the cerebellum. Quantitatively, the
largest effect was on the thalamus, but the collective results suggest a pervasive rather than a selective effect on the brain. Detailed analysis
of cortical gray matter revealed that cortical surface area displays a strong dose-dependent effect of CNV (deletion ⬎ control ⬎ duplication), whereas average cortical thickness is less affected. These results suggest that the CNV may exert its opposing influences through
mechanisms that influence early stages of embryonic brain development.
Key words: 16p11.2; ASD; CNV; copy number variation; morphometry; structural MRI

Introduction
The relationship between genetic variation and phenotypic expression has been difficult to resolve, especially in the context of
risk for neuropsychiatric disorders. Part of the complexity arises
because variations in large numbers of genes convey risk for the
same neuropsychiatric disorders, and because of the rarity of each
genetic etiology, limited analyses exist in individuals carrying the
same highly penetrant copy number variations (CNVs). For this
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reason there is need to study large numbers of individuals with
the same CNV that conveys risk for neuropsychiatric disorders.
The present study explores the effects of deletion and duplication of the recurrent ⬃600 kb BP4 –BP5 16p11.2 CNV. The
16p11.2 CNV is associated with a variety of neurodevelopmental
outcomes (Bijlsma et al., 2009; Rosenfeld et al., 2010; Shinawi et
al., 2010; Jacquemont et al., 2011; Hanson et al., 2014). The
16p11.2 CNV has drawn particular attention because of its association with autism spectrum disorder (ASD). In nonsyndromic,
idiopathic ASD this CNV occurs at a frequency of 0.76% (95%
CI, 0.51–1.12; Walsh and Bracken, 2011), which ties it as the most
common ASD risk variant alongside the maternal 15q11– q13
duplication (Cook and Scherer, 2008; Walsh and Bracken, 2011).
Carrying a 16p11.2 deletion increases the odds of developing
autism or developmental delay by 38.7-fold (95% CI, 13.4 –
111.8), whereas there is a 20.7-fold increase with the duplication
(95% CI, 6.9 – 61.7; McCarthy et al., 2009).
However, there is considerable phenotypic variability. Individuals meeting diagnostic criteria for ASD are a minority of
16p11.2 CNV carriers. In addition to associations with language
delay (83% require speech therapy), intellectual disability/developmental delay (on average ⬃2 SDs lower than controls), and
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Table 1. Demographics and neurocognitive characterization for participants enrolled in the advanced imaging protocol
Children
Adults

n
Mean age ⫾ SD
Range
Male:female
Left:right:ambi
FSIQ
NVIQ
Range (NVIQ)
SRS, ⱖ60
Vineland II, ⱕ85
SCQ, ⱖ15
ADI
ADOS

Controls

Deletion carriers

Controls

29
12.8 ⫾ 2
8 –17
19:10
4:25
109 ⫾ 13
108 ⫾ 11
80 –136
16 ⫾ 12 , 0/29
106 ⫾ 9 , 0/28
2 ⫾ 2 , 0/28
—
—

25
11.1 ⫾ 2*
8 –16
13:12
8:17*
86 ⫾ 13*
92 ⫾ 13*
65–130
71 ⫾ 41* , 16/25
84 ⫾ 13* , 16/25
10 ⫾ 8* , 6/25
11/19
7/25

33
37.1 ⫾ 9
19 –54
19:14
6:26:1
107 ⫾ 13
105 ⫾ 11
77–125
18⫾ 12 , 0/32
124 ⫾ 80, 1/7
—
—
—

Duplication carriers
17
36.1 ⫾ 9
20 –52
10:7
2:15:0
102 ⫾ 11
101 ⫾ 13
77–119
40 ⫾ 34* , 3/17
87 ⫾ 16* , 8/15
—
1/2
2/17

*Indicates significant differences. Handedness is grouped as left, right, ambidextrous (ambi). FSIQ, Full scale IQ; NVIQ, non-verbal IQ; SRS, Social Responsiveness Scale; SCQ, Social Communication Questionnaire; ADI, Autism Diagnostic
Interview; ADOS, Autism Diagnostic Observation Schedule. The ADI and ADOS were not collected on controls. The ADI was not collected on a subset of carriers.

ASD (15% meeting full diagnostic criteria; Zufferey et al., 2012),
16p11.2 is also associated with schizophrenia, bipolar disorder,
ADHD, epilepsy, and paroxysmal dyskinesia syndrome (Weiss et
al., 2008; McCarthy et al., 2009; Shinawi et al., 2010). These results suggest that the CNV has broad effects on multiple brain
systems. Interestingly, mirror phenotypes occur with deletion
carriers being associated with macrocephaly and obesity, whereas
duplication carriers are associated with microcephaly and low
body mass index (Jacquemont et al., 2011; Zufferey et al., 2012).
These opposing effects suggest that, for certain phenotypes, there
may be a consistent dose-dependent influence of the CNV.
In the present study, brain structure was analyzed in detail for
individuals carrying either a deletion or duplication of the
16p11.2 region. Participants were recruited as part of the Simons
Variation in Individuals Project (VIP; Simons VIP Consortium,
2012). Portions of the data have been analyzed previously in the
context of cognitive and behavioral phenotype (Hanson et al.,
2014) and in relation to white-matter microstructure (Owen et
al., 2014). Here we focus on morphometric analysis of brain
structure. Two questions motivated the analyses. First, are there
similar or opposing effects on brain structure between the
16p11.2 deletion and duplication carriers? Second, do observed
effects suggest a focal or pervasive influence on the brain?

Materials and Methods
Participants. Child deletion and adult duplication carriers of 16p11.2
CNV, as well as control subjects, were enrolled from a large cohort of
individuals as part of the advanced neuroimaging protocol of the Simons
VIP Project (Simons VIP Consortium, 2012). Individuals were recruited
in various ways including referral by clinical genetic centers or testing
laboratories, web-based networks, or by self-referral of families who
learned about Simons VIP (http://SimonsVIPconnect.org). Initial
screening and review of medical records occurred at Geisinger and Emory University. Only participants with recurrent breakpoints at BP4 –
BP5 of 16p11.2 without other pathogenic CNVs or other known genetic
diagnoses or syndromes were enrolled. Individuals were excluded if they
were not fluent in English, or had a history of environmental insults that
could affect neurocognitive status, such as fetal alcohol syndrome, severe
birth asphyxia, or severe prematurity.
All participants were enrolled in an initial level of study that took place
at three phenotyping core sites: University of Washington Medical Center, Baylor University Medical Center, and Boston Children’s Hospital.
Assessments included the Autism Diagnostic Observation Schedule
(ADOS), Autism Diagnostic Interview (ADI), broad screening measures
of social impairment such as the Social Responsiveness Scale (SRS),
Vineland-II, and Social Communication Questionnaire (SCQ), as well as
general measures of cognitive abilities with the Differential Ability Scale

(DAS-II), and Wechsler Individual Achievement Test (WIAT-III)
among others. A structural MRI scan was also obtained at the initial
assessment but was not matched across sites. Differences in MRI scanners
can affect morphometry results. For this reason, the structural MRI data
acquired at these sites was not included in our primary analysis.
A subset of these participants 8 years and older, and able to tolerate
MRI, were recruited to the second level of study focused on neuroimaging. Data acquisition occurred at two imaging core sites: University of
California sites (UC) and Children Hospital of Philadelphia (CHOP). All
aspects of the study at UC were performed at UC-San Francisco,
except for scanning, which was performed at UC-Berkeley to maintain conformity with the CHOP scanner. Subjects had structural MRI,
resting-state functional MRI, task-based functional MRI, diffusiontensor imaging (DTI) and magnetoencephalography collected on
matched scanner platforms.
The structural MRI scans obtained from the UC and CHOP neuroimaging sessions were the primary focus of this study. For a subset of targeted analyses, the structural MRI scans obtained from the initial
assessments at the phenotyping core sites were also analyzed.
Control participants for the imaging core sites (UC and CHOP) were
recruited locally from the general population matching for age, sex,
handedness, and nonverbal IQ. Individuals with any major DSM-IV
diagnosis were excluded (based on clinical psychologist review) or if an
immediate family member was diagnosed with ASD, other developmental disorders, dysmorphic features, or genetic abnormalities. Control
participants were also excluded for a Symptom Checklist 90 (SCL-90)
score ⬎62, an axis 1 psychiatric diagnosis on the Diagnostic Interview for
Children, a Broader Autism Phenotype Questionnaire aloof subscale
score ⬎4/3.5 (male/female), a pragmatics subscale score ⬎3.25/3.5, or a
rigidity subscale score ⬎4/3.7. Control subjects also had a chromosome
microarray, neurologic exam, a photograph evaluation for dysmorphology, and a clinical psychologist review.
Additional neuropsychiatric assessments were completed during the
neuroimaging visits. The battery included the DIAS-II, WIAT-III,
Wechsler Abbreviated Scale of Intelligence, Clinical Evaluation of Language Fundamentals (CELF-4), Clinical Test of Phonological Processing,
Delis-Kaplan Executive Function System (D-KEFS), Purdue Pegboard,
and Ishihara plates. Behavioral testing completed at the phenotyping
cores was not repeated on 16p11.2 carriers because this had already been
obtained. Carriers completed the CELF and D-KEFS during the neuroimaging visit.
High-quality structural MRI images from the neuroimaging core sites
were the primary data analyzed (Table 1). Twenty-five child deletion
carriers (13 male and 12 female) and 29 matched child-control subjects
(19 male and 10 female) were recruited (ages 8 –17). Similarly, 17 adult
duplication carriers (10 male and 7 female) along with 33 matched adultcontrol subjects (19 male and 14 female) were recruited (ages 19 –54). Of
the 54 children, 33 were imaged at UC and 21 at CHOP. Of the 50 adults,
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33 were imaged UC and 17 at CHOP. Insufficient numbers of child
duplication and adult deletion carriers were available for analysis.
Clinically obtained structural MRI images from the initial phenotyping core sites were analyzed for a specific set of follow-up questions (see
Table 5). These secondary data included age-matched child deletion
(N ⫽ 28) and duplication (N ⫽ 16) carriers as well as control siblings
who did not carry the 16p11.2 CNV (N ⫽ 21). Thus, although the structural sequences were not matched across sites for these secondary data,
the data were particularly valuable for testing specific hypotheses that
required age-matched deletion and duplication carriers, and also allowed
for assessment of the effects in relation to a family based control group.
Study procedures were approved by the institutional review boards at
UC, CHOP, University of Washington Medical Center, Baylor University Medical Center, Boston Children’s Hospital, Emory University, Geisinger Medical Center, Columbia University, and Harvard University.
Image acquisition and quality control. Structural imaging was performed at UC and CHOP on matched 3 tesla TIM Trio MRI scanners
(Siemens), one at each site, using the vendor-supplied 32-channel
phased-array radio-frequency head coils. Structural data included a highresolution multiecho T1-weighted magnetization-prepared gradient-echo image (ME-MPRAGE; van der Kouwe et al., 2008) using the following
parameters: TR ⫽ 2530 ms, TI ⫽ 1200 ms, TE ⫽ 1.64 ms, FA ⫽ 7°, 1 ⫻
1 ⫻ 1 mm, and FOV ⫽ 256 mm. Other images acquired following the
ME-MPRAGE were not analyzed here (e.g., DTI). The images were sent
to Harvard University for quality control and analysis. Images with severe wrapping, poor head coverage, ringing/striping/blurring, ghosting,
inhomogeneities, or susceptibility artifacts were not used in the analysis
(5 participants were discarded for quality).
Structural MRI data analysis. Structural morphometric analyses targeted total intracranial volume (ICV), whole-brain volume, cortical
white and gray matter volumes, cortical surface area and thickness, subcortical structures, and the cerebellum. In this manner, large overall
differences in brain organization could be identified as well as local differences that might represent selective differences. The T1-weighted
structural (ME-MPRAGE) images were analyzed using FreeSurfer version 4.5.0 software package (http://surfer.nmr.mgh.harvard.edu) using a
custom hybrid template consisting of 48 subjects (12 from each group:
child control, child deletion, adult control, and adult duplication). A
custom template mitigates atlas transformation errors that can occur
when the default target atlas has distinct contrast properties from the
sample or nonrepresentative anatomy (Buckner et al., 2004). Atlas registration for each individual was to this hybrid template. Images that
failed FreeSurfer processing, or had poor quality cortical parcellation and
subcortical segmentation were also removed from the analysis (N ⫽ 8
participants discarded, in addition to those removed for poor image
quality). FreeSurfer applies distinct automated algorithms for surfacebased cortical measures and voxel-based subcortical volumes (Dale et al.,
1999; Fischl et al., 1999, 2002; Fischl, 2012). Critical to our analyses,
cortical gray matter volume could be decomposed to its orthogonal components: surface area and cortical thickness.
For all structural measures, the effects of nuisance variables were removed. Linear regression on nuisance factors was performed using the
statistical software SPSS 21. All structural measures were covariancecorrected for age, sex, scanner site, and nonverbal IQ. The ␤ values for
each variable were used to compute adjusted measures in the original
units using the following formula:
VOLadj ⫽ VOLnat ⫺ [␤1(Agenat ⫺ Mean Agenat) ⫹ ␤2(Sexnat ⫺ Mean
Sexnat) ⫹ ␤3(Sitenat ⫺ Mean Sitenat) ⫹ ␤4(NVIQnat ⫺ Mean NVIQnat)],
where VOLnat is the uncorrected, raw volume measure for any given
volume, Agenat is the uncorrected age, Mean Agenat is the group mean,
and so on. The final covariance-corrected values, VOLadj, are reported
for each measure. Discussion of this normalization approach can be
found in Buckner et al. (2004). For analysis purposes, cortical surface
area and thickness were normalized in the same manner as the other
volumes.
One important feature of the analysis to note is that age regression was
performed separately for the children and adults to test the effects of
16p11.2 deletion in the children and duplication in the adults. For this
reason, we do not test, and do not interpret, direct contrasts between the
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child deletion and adult duplication carriers (or the child and adult controls). A sufficient number of child duplication and adult deletion carriers had not undergone the protocols at neuroimaging core sites to
directly test for CNV effect within a given age cohort. Two further independent analyses were performed to disentangle effects of age from effects of the CNV including a secondary analysis of the structural data
from the initial phenotyping sites.
Distinguishing effects of CNV from effects of age: allometric scaling. A
limitation of the present study is that data from neuroimaging core sites
were not available for child duplication or adult deletion carriers. Brain
volume is known to decrease with age beginning in young adults with a
gradual progression throughout the lifespan (Fotenos et al., 2005; Raz et
al., 2005). Given that ASD has in some studies been associated with brain
overgrowth early in development followed by variable patterns at later
stages (Courchesne et al., 2001, 2003; Redcay and Courchesne, 2005;
Schumann et al., 2010), differences between child deletion and adult
duplication carriers could be confounded by age in our study. A recent
study that examined head circumferences in 7225 individuals from 1891
families, each with one ASD child, showed a small but reproducible effect
of ASD diagnosis (Chaste et al., 2013).
To control for the effect of age, an analysis that exploits the allometric relationship between ICV and brain volume in young adults
was performed. In young adults, before brain volume loss due to
aging, there is an almost perfect allometric relationship between ICV
and brain volume: individuals with large brains possess large ICVs
and individuals with small brains possess small ICVs (Davis and
Wright, 1977, their Fig. 5). Brain volumes move away from the allometric line as individuals age and atrophy shrinks the brain away from
the skull covering. Fortuitously, ICV minimally changes with aging
(Davis and Wright, 1977; Buckner et al., 2004). It is for this reason
that ICV can be used as a regressor to increase sensitivity to the effects
of atrophy in studies of advanced aging. Here the stability of ICV
provided an anchor to determine whether CNV effects were due to
genetic differences or an effect of aging.
For all subjects, ICV was plotted against cortical gray matter volume.
The key feature of such a plot is that, within an age group, the gray matter
volumes fall along a line directly in relation to ICV. The effect of CNV can
be seen as a movement upward or downward along the age-appropriate
line. As the results will reveal, the data are well behaved. The effects of
deletion and duplication, albeit collected in different age groups, move
appropriately along their age-specific lines suggesting the effects are not
confounded by age.
Distinguishing effects of CNV from effects of age: clinical site MRI acquisitions. The primary data analyzed in the present study came from the two
neuroimaging core sites using matched scanner hardware and sequences.
All the subjects were also imaged on a structural protocol at their initial
testing sites on the available scanner at the site (Baylor University Medical Center, Boston Children’s Hospital, and University of Washington
Medical Center). Analysis of the most informative and robust measures
(ICV, brain volume, and gray matter volume) revealed that there was an
excellent correlation between the values obtained for the neuroimaging
site scans and the original clinical site scans despite platform differences
(r ⫽ 0.96 – 0.97). High quality data from a sufficient number of child
duplication (N ⫽ 16, mean age ⫽ 7.8 years, 10 male, mean NVIQ ⫽ 79)
and child deletion carriers (N ⫽ 28, mean age 9.9 years, 17 male, mean
NVIQ ⫽ 90) were available to conduct an informative analysis. Moreover, a unique family based control group comprised of unaffected
siblings was available (N ⫽ 21, mean age 8.1 years, 8 male, mean
NVIQ ⫽ 104). These data were used as another means to test for
effects of copy number minimizing the age confound. These data also
allowed for generalization of the primary findings to a family based
control sample (the deletion carriers overlapped substantially with
those enrolled at the neuroimaging core sites, but the duplication
carriers and controls were unique; see Table 5). These data were not
sufficient to test more subtle regional relations or effects that depend
on consistent, high contrast (e.g., cortical thickness).
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Results
Cognitive and behavioral phenotypes
Cognitive and behavioral phenotypes of the Simons VIP group of
16p11.2 deletion and duplication carriers described elsewhere
(Hanson et al., 2014; Zufferey et al., 2012, a portion of their data).
Here we focus on the specific sample that contributed qualitycontrolled data for the present study. These data represent a subset of the original sample.
Social impairment was common in both the deletion and duplication carriers (Table 1). The SRS and Vineland-II are nonspecific screening measures of social impairment. SRS ⱖ60 reflects
“at risk” individuals, and similarly Vineland-II scores ⱕ85 reflect
a “moderately-low to low” adaptive level. Child deletion carriers
(16/25 and 16/25) met screening cutoff for broad social impairment according to SRS and Vineland-II, respectively. Adult duplication carriers (3/17 and 8/15) also met these criteria. No child
controls met these cutoffs, whereas one adult control had a
Vineland-II score of 79. The SCQ is a screening test for ASD. A
score ⱖ15 is the cutoff for “possible ASD.” Six of 25 child deletion
carriers met this screening test for ASD, whereas no child controls
did. SCQ was not tested in adults. The ADI and the ADOS are
specific tests for ASD. Child deletion carriers (11/19 and 7/25)
tested positive on ADI and ADOS, respectively. Of these child
deletion carriers, a total of 14/25 were either positive for ADI or
ADOS. In adult duplication carriers, 1/2 and 2/17 tested positive
for ASD on ADI and ADOS, respectively.
The behavioral testing in Table 1 shows a progression from broad
features of social impairment to those specific to ASD. SRS and
Vineland-II are the broadest of the set, then SCQ screens for possible
ASD, and finally ADI and ADOS are specific to the deficits characteristic of ASD. Furthermore, abnormal tests were most frequent on
the broad level of SRS and/or Vineland-II, whereas only a few individuals tested positive for both ADI and ADOS. Consistent with
Hanson et al. (2014), our subsample of deletion and duplication
carriers shows variability in social impairment.
The study aimed to recruit controls who matched cases in
nonverbal IQ (NVIQ). Despite best efforts, there was a 16-point
difference between the child groups (t ⫽ 5.06, p ⬍ 0.001; Table 1).
No significant difference was seen in adults. Full scale IQ was not
controlled for and showed a similar pattern. A modest positive
correlation with IQ and brain volume, and in particular cortical
gray matter volume, has been observed in healthy children (Reiss
et al., 1996), as well as healthy adults (Andreasen et al., 1993).
Additionally, NVIQ differences between autism cases and controls can bias results (Piven et al., 1992). NVIQ was regressed
from the results to address this potential confound.
A significant difference in age was found between child deletion carriers and age-matched controls (t ⫽ 2.96, p ⬍ 0.01),
whereas no significant difference was found in adults. The study
also aimed to match for handedness; however, an excess of lefthanded individuals were recruited in the deletion group (⬃1:2 vs
⬃1:6 in child controls). Within the deletion group, left- and
right-handed individuals did not significantly differ in volume in
respect to ipsilateral and contralateral morphometry of cortical
gray matter volume, cortical white matter volume, surface area,
cortical thickness, or thalamus volume. Right-hemisphere cortical volume was increased in deletion carriers compared with the
left-hemisphere cortical volume, but this was also the case for
child controls. In contrast, right thalamus volume was smaller
than the left in deletion carriers. Handedness did not affect the
overall results. There were no significant differences in sex or

Table 2. Clinical diagnoses
Child

Adult

DEL, n ⫽ 25 (%) DUP, n ⫽ 17 (%)

DSM-IV diagnoses (codes)

Phonological Processing Disorder (315.39)
13 (52)
Developmental Coordination Disorder (315.4)
8 (32)
Language Disorders (315.31, 315.32, 307.9)
7 (28)
Enuresis (307.6)
6 (24)
Autism Spectrum Disorder (299.00, 299.80)
4 (16)
ADHD Diagnosis (314.00, 314.01, 314.9)
5 (20)
Intellectual Disability (317, 318, 319)
5 (20)
Behavior Disorder (312.9, 313.82)
4 (16)
Learning Disorders (315.0, 315.1, 315.2, 315.9)
3 (12)
Anxiety & Mood Disorders (300.0, 300.02, 300.4, 300.9) 3 (12)
Tic Disorder (307.2, 307.22, 307.3)
3 (12)
Macrocephaly
6 (24)
Microcephaly
0
Mean no. diagnoses per subject
2.7 ⫾ 2

0
1 (6)
0
0
1 (6)
3 (18)
1 (6)
0
1 (6)
7 (41)
0
0
4 (23)
1.0 ⫾ 1

Table 3. Radiological abnormalities
Radiologic abnormalities

Child
DEL, n ⫽ 25

Adult
DUP, n ⫽ 17

Cerebellar hemisphere
Craniocervical junction
Dens abnormality
Platybasia
Corpus callosum
Hippocampal commissure
Cortical malformation
Hippocampus
Pituitary
Thalamus
Anterior commissure
Optic nerve/chiasm
White matter volume
Ventricles
Cerebellar vermis
Basal ganglia
Brainstem

8
7
7
4
4
2
1
1
1
1
1
1
0
0
0
0
0

5
0
0
0
2
0
1
1
1
0
0
0
3
2
3
0
0

scanner site between groups. Results were covariance-corrected
for the nuisance factors of age, sex, scanner site, and NVIQ.
There is a potential for height to covary with head size. After
controlling for age and sex, height was not significantly different
between groups (children: t ⫽ 1.01, p ⫽ 0.32; adults: t ⫽ ⫺1.17,
p ⫽ 0.25). On the other hand, child deletions had significantly
higher BMI than controls (t ⫽ ⫺2.68, p ⬍ 0.01), whereas no
significant difference was seen in adults. Higher BMI can be expected based on prior studies (Jacquemont et al., 2011; Zufferey
et al., 2012), but the mirrored phenotype BMI phenotype was not
seen in adults as was previously reported in the U.S. cohort
(Zufferey et al., 2012; t ⫽ ⫺0.07, p ⫽ 0.94). Height and BMI were
not correlated in the sample as a whole (r ⫽ ⫺0.01), and mildly
correlated within groups (r ⫽ 0.17– 0.38). Finally, if ICV and
whole brain volume are normalized for height, results are not
significantly affected.
Clinical diagnoses
All participants were evaluated for DSM-IV diagnoses (Table 2).
A clinical diagnosis of ASD was based not only on ADI and ADOS
scores, but clinical criteria and overall clinical evaluation. Four of
25 (16.0%) child-deletion carriers met clinical criteria for ASD,
and 1/17 (5.9%) in adult duplication carriers. The prevalence in
the child cohort was similar to the larger cohort evaluated at the
phenotyping core sites from which the participants were re-
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Figure 1. Global measures of ICV and brain volume show opposing effects of 16p11.2 deletion and duplication. 29 child
controls, 25 child-deletion carriers, 33 adult controls, and 17 adult duplication carriers are included in this analysis (Table 1). A,
Mean adjusted ICV is plotted for the child deletion (DEL) carriers versus their age-matched controls and the adult duplication (DUP)
carriers versus their age-matched controls. The values are adjusted via regression for age, sex, scanner site, and NVIQ. Deletion
carriers show a significant increase in volume and duplication carriers a significant decrease in volume. Deletion carriers show a
⫹7.5% differences from controls, and duplication carriers show a ⫺6.8% differences from controls. Asterisks indicate significance
with a double-asterisk reflecting p ⬍ 0.01 and a triple-asterisk representing p ⬍ 0.001. Errors bars represent SEM. B, Mean
adjusted brain volume is plotted similarly. Brain volume includes cortical gray matter, cortical white matter, subcortical structures,
brainstem, and cerebellum without the volume encompassed by ventricles or the subarachnoid space. The pattern for brain volume
differences parallels that observed for ICV. Deletion carriers show a ⫹9.7% difference from controls, and duplication carriers show
a ⫺9.3% difference from controls.

Figure 2. Brain volume in individuals. Data illustrate individual participant values for the group data displayed in Figure
1. A, A scatterplot of brain volume is plotted by age before regression of nuisance factors (age, sex, scanner site, and NVIQ).
This plot makes transparent the effect of age within and across groups. A decrease in brain volume is seen with age,
cross-sectionally across controls. Direct comparison of 16p11.2 carriers across age cannot be made because the cohorts are
absent adult deletion and child duplication carriers. B, A scatterplot of adjusted brain volume by age reveals the effects at
the level of individual participants. Within each age group-children (⬍18) and adults (ⱖ18), the effect of age is removed
via regression. Age is plotted to allow the individual subjects to be visualized in relation to their age with all nuisance
effects except carrier status removed (age, sex, scanner site, and NVIQ). The resulting scatter plot is well behaved and
reveals that the effect of CNV is highly penetrant as the full distribution of deletion and duplication carriers are shifted
relative to their controls. Almost all child-deletion carriers were above the mean for their controls (mean ⫽ 1277 cm 3).
Similarly, most of the duplications were below the mean for their controls (mean ⫽ 1204 cm 3). The effects were not driven
by the few individuals with clinical macrocephaly or microcephaly.

cruited (Zufferey et al., 2012). Additionally, only those participants from the phenotyping core sites who could best tolerate
imaging were included, which is a selection bias toward higher
functioning individuals who can lie still in the scanner. The lower
prevalence of ASD in adults compared with children may be due
to duplications being less impactful than deletions, or to a selection difference (adults were often identified as carriers after clinical identification of a proband and then subsequent cascade
genetic testing in the family such that carrier status in the pro-

band would trigger testing in first degree
relatives, then second, etc.). The deletion
and duplication carriers were given a
broad range of DSM-IV diagnoses (Table
2). Of note, none of the 16p11.2 carriers
was given a diagnosis of schizophrenia.
Schizophrenia has been associated with
decreased brain volume (Crespi and Badcock, 2008), which could have potentially
confounded adult duplication data if such
diagnoses were present.
Radiographic abnormalities were
also noted for deletion and duplication
carriers (Table 3). Controls did not
show radiologic abnormalities that
would exclude them from analysis. Minor findings included occasional white
matter hypointensities, small mega cisterna
magnas, small arachnoid cysts, ectopic tonsils, empty sella syndromes, and mild cortical atrophy in some older adults.
Structural estimates were reliable
Participants were imaged across two sites
(UC and CHOP) that were matched for
scanner hardware and sequences. Effort
was made to align details of imaging including placement of the head within the
scanner. Nonetheless, reliability across
sites was an open question. For this reason, five individuals not participating in
the study were scanned at both sites with
data analyzed independently for each acquisition using the same procedures as for
the target cohort (mean age ⫽ 34.6; 4
male). Mean group differences between
sites were marginal for these subjects in
terms of ICV (UCmean ⫽ 1687 cm 3,
CHOPmean ⫽ 1682 cm 3, t ⫽ ⫺0.04,
p ⫽ 0.97), cortical gray matter volume
(UCmean ⫽ 540 cm 3, CHOPmean ⫽ 549
cm 3, t ⫽ 0.49, p ⫽ 0.64), surface area
(UCmean ⫽ 189 cm 2, CHOPmean ⫽ 191
cm 2, t ⫽ ⫺0.22, p ⫽ 0.83), and average
cortical thickness (UCmean ⫽ 2.53 mm,
CHOPmean ⫽ 2.56 mm, t ⫽ ⫺1.52, p ⫽
0.29). Although correlation is not properly
estimated with such a small sample size, the
intraclass correlation (ICC) was calculated:
intracranial volume ICC ⫽ 0.97, cortical
gray matter volume ICC ⫽ 0.93, surface
area ICC ⫽ 0.99, and cortical thickness
ICC ⫽ 0.85.

Deletion and duplication carriers display opposing effects on
global measures of brain volume
Prior studies have shown that deletion carriers have increased
head circumference, whereas duplication carriers have decreased
head circumference (McCarthy et al., 2009; Shinawi et al., 2010;
Jacquemont et al., 2011; Zufferey et al., 2012). Clinicians use head
circumference as a rough measure for intracranial volume. Estimated ICV in this study corroborated prior results. ICV was increased for deletion carriers compared with their controls (t ⫽
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Table 4. Percentage structure brain differences in CNV carriers relative to their
controls
Without ICV correction
With ICV correction
Deletion carriers Duplication carriers Deletion carriers Duplication carriers
ICV
ⴙ7.5%
Brain volume ⴙ9.7%
Gray matter
ⴙ8.8%
White matter ⴙ12.7%
Surface area
ⴙ7.1%
Thickness
⫹0.8%
Hippocampus ⫹5.4%
Amygdala
⫹3.4%
Cerebellum
ⴙ5.9%
Thalamus
ⴙ11.3%
Caudate
⫹2.9%
Putamen
⫹2.8%
Brainstem
ⴙ9.2%

ⴚ6.8%
ⴚ9.3%
ⴚ8.3%
ⴚ11.1%
ⴚ6.6%
ⴚ1.7%
ⴚ6.5%
⫺6.0%
ⴚ7.7%
ⴚ10.8%
⫺6.5%
⫺3.7%
ⴚ10.5%

—
⫹1.5%
⫹1.0%
⫹2.4%
⫺1.0%
⫹0.8%
0.0%
⫺2.6%
⫹0.7%
ⴙ5.0%
⫺0.1%
⫺0.9%
⫹3.5%

—
ⴚ2.9%
⫺2.0%
ⴚ3.9%
⫺1.4%
ⴚ1.8%
⫺4.0%
⫹0.6%
⫺3.3%
ⴚ4.8%
⫹2.2%
⫹0.2%
⫺3.9%

The two leftmost columns reflect percentage differences between CNV carriers and controls without normalization
for ICV. Differences reaching significance ( p ⬍ 0.05) are displayed in boldface type to help visualize general patterns. The two rightmost columns display the same data with differences normalized for ICV. Note that except for the
thalamus and a few other values, the differences are minimal after normalization by ICV.

Figure 3. Both cortical gray matter and cortical white matter show opposing effects of
16p11.2 deletion and duplication. Included participants are the same as Figure 1. A, Mean
adjusted cortical gray matter is plotted for the child deletion (DEL) carriers versus their agematched controls and the adult duplication (DUP) carriers versus their age-matched controls.
Like global brain volume plotted in Figure 1, deletion carriers show a significant increase in
volume and duplication carriers a significant decrease in volume. Deletion carriers show a
⫹8.8% difference from controls, and duplication carriers show a ⫺8.3% difference from controls. Asterisks indicate significance, with a double-asterisk reflecting p ⬍ 0.01, and a tripleasterisk representing p ⬍ 0.001. Errors bars represent SEM. B, Mean adjusted white matter
volume is plotted similarly. Deletion carriers show a ⫹12.7% difference from controls, and
duplication carriers show a ⫺11.1% difference from controls.

⫺3.05, p ⬍ 0.01), and decreased for duplication carriers compared with their controls (t ⫽ 3.78, p ⬍ 0.001; Fig. 1A). If the
results are also normalized for height the t test value increases
slightly in children (t ⫽ ⫺3.19, p ⬍ 0.01), and adults (t ⫽ 4.11,
p ⬍ 0.001). Whole-brain volume was also revealed to be larger in
child deletion carriers compared with controls (t ⫽ ⫺3.55, p ⬍
0.001), and smaller in adult duplication carriers compared with
controls (t ⫽ 5.67, p ⬍ 0.001; Fig. 1B). If the results are also
normalized for height the t test value increases slightly in children
(t ⫽ ⫺3.68, p ⬍ 0.001), and remain stable for adults (t ⫽ 5.53, p ⬍
0.001). Because height has a minimal influence on global measures,
subsequent results are only covariance-corrected for age, sex, scanner site, and NVIQ.

The CNV effects on brain volume did not appear to be driven
by a few individuals who were diagnosed with clinical micro/
macrocephaly. Instead it appears that the deletion and duplication broadly shift the distributions of brain volumes consistent
with a highly penetrant effect on brain volume observable on the
individual participant level before (Fig. 2A) and after correction
for nuisance variables (Fig. 2B). This is an important observation
as diagnosis of clinical macrocephaly requires an extreme deviation from the group central tendency (head size ⬎2 SDs above the
mean) which may not fully capture the effects on all individuals as
a brain volume increase or decrease in an individual may still
leave him or her within the “normal” range of the brain volume
distribution simply because there is considerable normal variation (Moreno-De-Luca et al., 2013).
Relevant to this point, although diagnosis of clinical macrocephaly has been associated with idiopathic autism in only ⬃15–
20% of cases (Lainhart et al., 1997; Stigler et al., 2011), increased
mean brain volume is a robust phenomenon in autism in particular at early ages (Redcay and Courchesne, 2005). For instance,
Courchesne et al. (2001) found that 90% of 2- to 4-year-old
autistic boys had whole-brain volumes above the mean for controls, and only one normal boy had a brain volume that exceeded
the autistic mean. One meta-analysis estimated a 5–10% increase
in total brain volume for children ages 1.5– 4 years old (Amaral et
al., 2008). Our cohort of 16p11.2 deletion carriers was similar.
Twenty-four percent (6/25) of child-deletion carriers had clinical
macrocephaly. More impressive is the fact that almost all childdeletion carriers were above the mean for their controls (mean ⫽
1277 cm 3), and had an effect size of a mean whole brain volume
9.7% larger than controls. Duplication carriers possessed a mirror opposite pattern; 23.5% (4/17) had clinical microcephaly and
a decrease in mean whole-brain volume by 9.3% below that of
controls (mean ⫽ 1204 cm 3). Thus, it is likely that carrier status,
age, gender, and genetic background all play significant roles in
the observed head size in the 16p11.2 cohort, but that carrier
status is the common element and hence most observable.
The effect on brain volume was also observed when cortical
gray matter volume (Fig. 3A) and white matter volume (Fig. 3B)
were analyzed separately. Child-deletion carriers showed increased volume compared with controls (cortical gray matter: t ⫽
⫺3.06, p ⬍ 0.01; cortical white matter: t ⫽ ⫺3.54, p ⬍ 0.001),
whereas adult duplications showed decreased volume compared
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Fig. 4C). A trend toward significance was
observed for the amygdala in adults (t ⫽
1.95, p ⫽ 0.06) and hippocampus in children (t ⫽ ⫺1.90, p ⫽ 0.06). Amygdala
volume in children was not significant
(t ⫽ ⫺1.25, p ⫽ 0.22). In idiopathic autism total cerebellum volume has been
found to be increased (Hardan et al., 2001;
Herbert et al., 2003; Palmen et al., 2005).
The thalamus (Hardan et al., 2008), hippocampus (Aylward et al., 1999; Sparks et
al., 2002; Schumann et al., 2004), and
amygdala (Aylward et al., 1999; Pierce et
al., 2001; Schumann et al., 2004, 2009)
have revealed divergent findings (for review, see Stigler et al., 2011).
To better understand the relationships
across the various measures of brain structure, Table 4 displays the differences in
structural brain volumes estimated as a percentage difference from the age-matched
control group. In this manner, for each
structure, the effect of CNV can be appreciated as a quantitative value. The effects are
pervasive and roughly of similar magnitude
across most structures. Of all individual
structures, the thalamus shows the greatest
difference, although it is difficult to interpret
small relative differences between structures
given differences in baseline structure size as
well as idiosyncratic features that arise in
templates used as the target for estimation.
As another way to display relationships
Figure 4. Opposing effects of 16p11.2 deletion and duplication are pervasive. Included participants are the same as Figure 1. across measures, Table 4 also displays the
Mean adjusted volumes are plotted for multiple structures revealing a consistent effect of deletion and duplication including for the percentage differences after correction for
(A) cerebellum, (B) thalamus, (C) hippocampus, and (D) amygdala. Percentage differences for deletion and duplication carriers are ICV. This removes the global effect of head
⫹5.9/⫺7.7 (cerebellum), ⫹11.3/⫺10.8 (thalamus), ⫹5.4/⫺6.5 (hippocampus), and ⫹3.4/⫺6.0% (amygdala) respectfully.
size and estimates the differences that are
Asterisks indicate significance with a single asterisk reflecting p ⬍ 0.05, double-asterisk reflecting p ⬍ 0.01, and a triple-asterisk
present that are beyond those accounted for
representing p ⬍ 0.001. Dagger represents a trend ( p ⫽ 0.06). Errors bars represent SEM.
by global head size differences. Head size
normalization attenuated most of the differwith controls (cortical gray matter: t ⫽ 4.03, p ⬍ 0.001; cortical
ences suggesting that a single global effect accounts for much of the
white matter volume: t ⫽ 5.07, p ⬍ 0.001). The percentage
results. An exception is the thalamus, which remains significantly
change in 16p11.2 carriers compared with controls was ⬃11.9%
larger in deletion carriers (t ⫽ ⫺2.37, p ⬍ 0.05) and smaller in
in white matter volume and ⬃8.5% in gray matter (Table 4). A
duplication carriers (t ⫽ 2.46, p ⬍ 0.05) after accounting for the
few studies with young children (1.5– 4 years) with idiopathic
global effect of head size. Duplication carriers also were significantly
autism found greater increases in white mater than gray matter
smaller than controls in brain volume (t ⫽ 3.84, p ⬍ 0.001), cortical
(Courchesne et al., 2001; Herbert et al., 2003; Hazlett et al., 2005;
white matter (t ⫽ 2.55, p ⬍ 0.05), and in cortical thickness (t ⫽ 2.18,
for review, see Amaral et al., 2008). In the present study, the agep ⬍ 0.05), but a significant difference was not found in deletion
associated increase in white matter volume in controls is difficult to
carriers. Note that the results reported throughout this paper do not
interpret because the two cohorts were normalized within their age
correct for ICV.
groups, nonetheless it may be a real effect consistent with observed
increases in estimated volume that occur in adolescence (Matsuzawa
Allometric scaling plots suggest brain differences are due to
et al., 2001; Barnea-Goraly et al., 2005; Perrin et al., 2008).
genetic effects not age
The above results all converge to suggest that brain volumes are
Opposing effects extend broadly to multiple subcortical
larger for deletion carriers and smaller for duplication carriers. Howvolumes and the cerebellum
ever, the two groups, in our study, confound age. It could be the case
The effect of 16p11.2 on brain volume is not limited to cerebral
that during childhood both deletion and duplication carriers have
cortex. Cerebellum volume is significantly increased in child deincreased brain volumes compared with controls, and as adults both
letion carriers (t ⫽ ⫺2.33, p ⬍ 0.05) and significantly decreased
deletion and duplication carriers have decreased brain volumes
in duplication carriers (t ⫽ 3.64, p ⬍ 0.001; Fig. 4A). Subcortical
compared with controls. This would be consistent with the agemeasures also show this same pattern, including the thalamus
specific anatomical changes that have been reported for idiopathic
(children: t ⫽ ⫺4.12, p ⬍ 0.001; adults: t ⫽ 4.73, p ⬍ 0.001; Fig.
autism, in which brain overgrowth occurs in early life, and later life is
4B) and the hippocampus in adults (adults: t ⫽ 2.90, p ⬍ 0.01;
characterized by arrested growth or decline below normal levels
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(Courchesne et al., 2011). If this effect is
present for our dataset then a single nonuniform process might be present in 16p11.2
carriers, instead of two opposing processes.
To control for age, Figure 5 plots gray matter volume in relation to ICV. Within an age
group, the two values show allometric scaling such that values tend to fall along a
line (Davis and Wright, 1977). This plot
demonstrates that well-behaved allometric
scaling is observed here within the age cohorts. The effect of age can be seen as a
downward shift between the child controls
(light green circles) and adult controls (dark
green circles). Critically, 16p11.2 deletion
and duplication carriers shift along their
own age-appropriate lines. Deletion carriers
(red triangles) cause a rightward shift, and
duplication carriers (blue squares) cause a
leftward shift. In other words, the effect of
age is dissociable from the effect of the CNV.
Analysis of clinically acquired MRI
Figure 5. The allometric scaling plot of intracranial volume versus cortical gray matter suggests age is not a confound. The four
groups of subjects are plotted in separate colors. Best-fit lines are drawn for the child groups (light green circle and red triangle) and
suggest brain differences are due to
separately for the adult groups (dark green circles and blue squares). The resulting lines are nearly parallel but shifted in their
genetic effects not age
In an effort to further explore the infer- y-intercept. This downward shift in the adults represents the expected cortical gray matter volume loss due to aging. Critically,
ences drawn from allometric scaling plots, within each age group, the CNV carriers move along their respective lines. The child-deletion carriers move upward to the right
clinically acquired MRI images were ob- reflecting a brain volume enlargement appropriate for their age group. The adult-duplication carriers move downward to the left
reflecting a brain volume loss appropriate for their age group. These results are consistent with opposing volumetric effects of
tained from the phenotyping core sites. deletion and duplication that are not confounded by age.
This superset provided a sufficient number of child deletion carriers, unaffected
Table 5. Demographics and neurocognitive characterization for participants
siblings as controls, and the group missing from our primary
enrolled in the supplemental clinical imaging sample
analysis, child duplication carriers. Although a larger sample was
Children
available in the superset only a portion of these MRI images met
Controls
Deletion carriers
Duplication carriers
5).
quality control standards (Table
Whole-brain volumes of child duplication carriers were found
n
21 (0)
28 (14)
16 (0)
to be significantly smaller than controls (t ⫽ 3.25, p ⬍ 0.01), and
Mean age ⫾SD
8.1 ⫾ 3
9.9 ⫾ 4
7.8 ⫾ 5
Range
1–15
1–16
1–16
significantly smaller than child deletion carriers (t ⫽ 6.36, p ⬍
Male:female
8:13
17:11
10:6
0.001). Additionally, brain volumes of child deletion carriers
L:R:ambi:Unk
1:16:2:2
4:17:5:2
2:8:1:5
were significantly larger than controls (t ⫽ ⫺2.71, p ⬍ 0.01; Fig.
FSIQ
106 ⫾ 10
86 ⫾ 15
78 ⫾ 12
6). This cohort allowed for direct comparison of child deletion
NVIQ
104 ⫾ 9
90 ⫾ 14
79 ⫾ 16
with child duplication carriers, which was not available in the
Range (NVIQ)
89 –120
64 –130
57–114
primary dataset. The results further support that reciprocal
SRS, ⱖ60
20 ⫾ 20 , 1/20
78 ⫾ 40 , 17/25
81 ⫾ 39 , 9/12
16p11.2 CNVs lead to opposing effect on brain volume, instead of
Vineland II, ⱕ85
103 ⫾ 11 , 1/21
78 ⫾ 11 , 23/28
78 ⫾ 12 , 12/16
SCQ, ⱖ15
2 ⫾ 2 , 0/20
11 ⫾ 9 , 8/25
14 ⫾ 7 , 5/11
a singular process of brain overgrowth. Courchesne et al. (2011)
ADI
0/1
10/20
8/11
report of “age-specific anatomical changes in autism” noted
ADOS
0/21
8/28
3/16
larger brain volumes in 2- to 4-year-olds, and smaller brain volAbbreviations as described in Table 1. The number in parenthesis denotes how many participants from the main
umes as early as 8- to 16-year-olds. The age sampling in our
analysis of the neuroimaging protocol overlapped with the clinically acquired MRI scans included in the secondary
cohorts are not sufficiently powered to explore effects between
analysis. The controls and duplication carriers were unique, but half of the deletion carriers overlapped between the
two sets of analyses.
these age ranges.
Cortical volumetric differences are greater in surface area
than thickness
Both surface area and cortical thickness contribute to cortical
gray matter volume, thereby affecting whole brain volume. Expanded cerebral surface area across species is hypothesized to be
due, in part, to an increase in the size of the progenitor cell pool
through an extended growth phase that disproportionately affects cortical surface area over thickness, i.e., from mouse to human there is a 1000-fold increase in surface area and only a
approximately twofold increase in cortical thickness (Rakic,
1988). For this reason, although there are likely multiple factors
that affect cortical surface area and thickness across individuals

(Hill et al., 2010 for analysis of postnatal effects), differential
effects of genetic dosage on thickness versus surface area are particular informative. Prior studies have found these two measures
to be genetically and phenotypically distinct (Panizzon et al.,
2009; Winkler et al., 2010).
To explore differential effects on the cerebral cortex, we estimated differences in cortical thickness separately from cortical
surface area. No significant difference in cortical thickness was
observed in children (t ⫽ ⫺1.10, p ⫽ 0.28). A significant, but
modest, difference was observed in adults (t ⫽ 2.28, p ⬍ 0.05). A
significant difference was observed in surface area for both children (t ⫽ ⫺2.40, p ⬍ 0.05) and adults (t ⫽ 4.22, p ⬍ 0.001).
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penetrant effect of gene dosage rather
than an effect on a subset of individuals.
Analysis of relative size scaling between
structures and follow-up analyses of child
cohorts with age-matched deletion and
duplication carriers suggest that the opposing brain phenotypes are stable across
the lifespan from children to adults.
Moreover, the differences are pervasive
across brain structures including the cortex, subcortical structures, cerebellum,
and brainstem. If the main effect of head
size is removed, only thalamic volume
remained significantly different in both
deletion and duplication carriers. Interestingly, on closer analysis of cortical gray
matter volume, cortical thickness was
minimally affected, whereas surface area
was markedly different from controls.
16p11.2 influences brain volume in a
dose-dependent manner
Broadly speaking, a general symmetry was
observed in the deviation from the mean
value of controls. The percentage difference was approximately equal on the most
robust structural brain measures between
Figure 6. Direct comparison of clinical MRI scans in children suggests volumetric effects reflect copy number relative to a family deletion and duplication carriers (Table
based control group. 21 child controls (CON), 28 child deletion (DEL) carriers, and 16 child duplication (DUP) carriers are included in 4): ICV (⬃7%), brain volume (⬃9%),
this analysis (Table 5). Controls are unaffected siblings of the probands. A, Mean adjusted brain volume in children is plotted. surface area (⬃7%), cortical thickness
Deletion carriers show a significant increase in brain volume compared with controls. Duplication carriers show a significant (⬃1–2%), etc. This suggests that 16p11.2
decrease compared with controls. Also significant is the difference between deletions and duplication carriers. Asterisks indicate influences brain structures in a dosesignificance with a double asterisk reflecting p ⬍ 0.01, and a triple asterisk representing p ⬍ 0.001. Error bars represent SEM. B,
dependent manner: one copy of the CNV
Scatterplot of brain volume versus age before regression of nuisance factors. Age-related differences between groups over child(deletion) is associated with abnormally
hood are not easily observable as the growth of brain volume is dramatic from birth until the age of 8, although hints of the CNV’s
effects are present. C, Scatterplot of adjusted brain volume versus age reveals the effect of the CNV on the individual level. This plot large brain volume (⫹9%), whereas two
is corrected for nuisance variables (age, sex, scanner site, and NVIQ) and should not be considered an accurate display of age effects. copies (controls) lead to typical development (reference), and three copies (dupliThe effect of the CNV is evident even at 1 year of age before stabilization of head size.
cation) are associated with abnormally
small brain volume (⫺9%). Dosagedependence implies a linear relationship
Quantitatively, the effect size was considerably greater for surface
between copy-number and gene expression. This is consistent
area. Put into context, in children, 89.9% of the gray matter volwith the dosage-dependent gene expression observed in a mouse
ume differential was accounted for by surface area, whereas only
model of 16p11.2. Horev et al. (2011) found mRNA expression to
10.1% was accounted for by differences in thickness. Similarly, in
be significantly altered in all brain regions evaluated such that
adults, 79.4% of the gray matter volume differential was acgene expression was directly correlated with dosage. Furthercounted for by surface area, whereas 20.6% was accounted for by
more, gene expression was affected much more by dosage comthickness. These differences could be appreciated at the individpared with the change in gene expression by brain region effect
ual subject level in the scatter plots (Fig. 7C,D). Increased cortical
(comparing the cortex, cerebellum, brainstem, and optic nerves;
thickness has been observed in autism (Hardan et al., 2006), but
Horev et al., 2011). Their analysis may explain the general symat least in 16p11.2 the reciprocal differences in cerebral gray matmetry in percentage change from controls observed in the present
ter volume are preferentially accounted for by differences in corstudy for a given structure, while at the same time allowing for
tical surface area.
some variation across brain structures.

Discussion

CNV at 16p11.2 has opposing and pervasive effects on the brain.
A mirrored head size phenotype has been previously observed,
but no prior studies in humans have directly evaluated brain
structure in 16p11.2 carriers. We found opposing brain phenotypes, such that deletion carriers have increased brain volume
compared with controls and duplication carriers have decreased
brain volume compared with controls. The effects were robust
and could be observed in individuals allowing insight into how
the CNV affected the distribution. The effect appeared to shift the
overall distribution of brain volumes consistent with a highly

The effects are pervasive across brain structures
Explorations of the 16p11.2 CNV and the included genes in animal models have reported involvement of widespread brain
structures. Cerebellum, basal ganglia, brainstem, and optic nerve
involvement has been reported in mouse models of 16p11.2
(Horev et al., 2011; Portmann et al., 2014). A study using zebrafish embryos systematically altered gene expression for each of
the 29 genes encompassed by 16p11.2, and found KCTD13 expression levels to be a primary driver of the head size phenotype
(Golzio et al., 2012). Systematic overexpression of the mRNA
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transcript exclusively of KCTD13 caused
microcephaly, whereas splice-blocking
the KCTD13 message with morpholinos
produced macrocephalic embryos (with
no differences in somatic trunk size).
Early in development KCTD13 transcript
was found to be strongly expressed at the
anterior forebrain, midbrain, and hindbrain 24 h postfertilization (Golzio et al.,
2012).
A major aim of the current study was
to provide greater detail as to which brain
structures are affected in humans with the
16p11.2 CNV. Brain volume in the present study is a composite measurement of
all brain structures: cortical gray matter,
cortical white matter, thalamus, basal
ganglia, limbic structures, cerebellum,
and brainstem, without the voxels in the
ventricles (https://surfer.nmr.mgh.harvard.
edu/fswiki/MorphometryStats). A significant difference in brain volume between
carriers and controls is analogous to the
results found in the animal work. The detailed morphometric analyses allowed us
to unpack this observation further.
Both cortical gray matter and white
matter volume were significantly larger/ Figure 7. Deletion and duplication of the 16p11.2 region preferentially influence cortical surface over cortical thickness. Insmaller than controls. Subcortical structures, cluded participants are the same as Figure 1. A, Mean cortical thickness measured as the radial distance from the white-gray
such as the thalamus and hippocampus, junction to the pial surface is plotted. Deletion carriers show a ⫹0.8% difference from controls, and duplication carriers show a
were also significantly different from con- ⫺1.7% difference from controls. Errors bars represent SEM. B, Mean surface area is plotted. Deletion carriers show a ⫹7.1%
trols. The amygdala and striatum (cau- difference from controls, and duplication carriers show a ⫺6.6% difference from controls. Asterisks indicate significance with a
date and putamen) did not reach single asterisk reflecting p ⬍ 0.05 and a triple-asterisk representing p ⬍ 0.001. C, D, Scatterplots of cortical thickness and surface
significance, which may be related to in- area reveal the effects at the level of individual participants. Although there is a modest effect of cortical thickness, there is a clear
and substantial effect on cortical surface area that can be observed in individual subjects including for the children.
adequate power in the study as they
trended in the same direction as the other
ASD phenotype. This model provides one explanation for the
structures with approximately the same magnitude of volume
disparity in our dataset between the high penetrance and expresdifferences. Cerebellum and brainstem volumes also reached sigsivity seen in brain volume versus the reduced penetrance and
nificant levels. These results highlight the pervasive effect of
variable expressivity seen with the ASD phenotype. The disparity
16p11.2 across brain structures. This in turn suggests involvemay be representative of the complex nature of 16p11.2 CNV
ment of 16p11.2 early in development, as the prosencephalon
with its phenotypes, and not an apparent sample bias toward
(cortex and thalamus), mesencephalon, and rhomboencephafewer carriers with ASD. Thus, changes in brain volume itself may
lon (brainstem and cerebellum) are all influenced. The thalaprovide insight into the core pathobiology of ASD in 16p11.2 carrimus was the only structure that retained significance in both
ers despite differences in penetrance and expressivity.
deletion and duplication carriers after regressing ICV as a
covariate (Table 4). This suggests that thalamic volume increased in deletion carriers and decreased in duplication carPreferential influence on surface area suggests a candidate
riers to a greater degree than the overall head size differences.
mechanism for abnormal brain size
Collectively, the effects across brain structures are pervasive.
An informative finding in this study was the preferential influence of 16p11.2 on surface area in contrast to a minimal effect on
The brain volume phenotype may share the same genetic
cortical thickness. This preferential effect on surface area prounderpinnings as ASD in 16p11.2
vides insight into when in development the 16p11.2 CNV derails
Case reports provide some evidence that KCTD13 may also be a
typical development. Alterations in cortical thickness can occur
primary driver of the ASD phenotype (Crepel et al., 2011; Golzio
either during embryonic formation or postnatally as a result of
et al., 2012). If brain volume and ASD phenotypes share a prisynaptic exuberance and pruning (Stiles and Jernigan, 2010). The
mary driver on 16p11.2, then this CNV may be best modeled as a
expansion of cortical surface area is strongly affected in the early
“simplex cis-epistatic” CNV, where dysfunction of a primary
embryo via increased progenitor cell production (Rakic, 1988)
driver is necessary and sufficient for multiple phenotypes but it is
consistent with the effects of manipulating KCTD13 in the zesubject to epistatic modulation by other genes on the CNV. Adbrafish (Golzio et al., 2012). In particular, augmentation of the
large pool of self-renewing progenitor cells in the outer subvenditionally, epistatic modifiers heavily influence penetrance and
tricular zone could account for differences in surface area in
expressivity (Golzio and Katsanis, 2013). MVP and MAPK3 modify KCTD13’s effect on head size (Golzio et al., 2012), whereas a
16p11.2 deletion and duplication carriers (Hansen et al., 2010;
Lui et al., 2011). Moreover, the involvement of MAPK3 is also
different set of epistatic modifier genes could contribute to the
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consistent with findings in patients, as alterations of the RASMAPK pathway can lead to macrocephaly in Costello syndrome
(Gripp et al., 2010, 2011). The differential effect on cortical surface area is not a definitive marker of an early embryonic mechanism as postnatal growth of human surface area has also been
observed in particular for association regions (Hill et al., 2010).
Nonetheless, the convergence between the mechanistic work in
the zebrafish suggesting an early embryonic mechanism affecting
cell proliferation and the pervasive, highly penetrant effect on the
human brain that is preferential to cortical surface area over
thickness is intriguing.
Limitations
A limitation of the present study is that the sample in unlikely
representative of the full population of 16p11.2 deletion and duplication carriers. Only probands with deficits severe enough to
warrant clinical evaluation and carrier parents well enough to
seek recruitment were ascertained, which selected for more severely impaired children and less affected parents. Furthermore,
only the subset of carriers that were capable of lying still in an
MRI scanner proceeded to the neuroimaging core sites, which
may have precluded the most severely affected carriers. Inadequate recruitment of child duplication and adult-deletion carriers prevented direct analysis of all six groups for all brain
measures; however, the core result (reciprocal increase and decrease in brain volume) was observed in a subset of age-matched
child deletion and duplication carriers (Fig. 6). The study was not
powered for subgroup analysis between de novo and inherited
cases. Hanson et al. (2014) have noted significantly greater impairment on SRS and NVIQ in de novo versus inherited cases.
Moreover, many of our analyses of deletion and duplication carriers used matched controls in the general population (Fig. 6 is an
exception, as it used a family based control group). Thus, other
genetic effects transmitted by noncarrier parents were not controlled for in the analyses of brain region volumes. Despite this
heterogeneity, we were still able to see robust changes in both
groups of carriers, independent of the clinical severity of the
groups.
As with all morphometric measures of brain structure, subtle
differences in data quality and image contrast (which covaries
with age) can affect measurements. These technical concerns
should be kept in mind especially when interpreting regional
(spatially specific) effects and differential effects on tissue compartments (white matter versus gray matter). We screened the
data carefully for data quality and generally found pervasive effects that could be observed at the level of individuals across the
age spectrum. That said, the preferential effect on the thalamus
(for both deletion and duplication carriers) and the differential
effect on surface area over thickness should be explored with
independent methods (e.g., manual assessment and postmortem
analysis). Of the various measures, although still showing high
reliability, cortical thickness showed the least stable reliability
(ICC ⫽ 0.85).
Conclusions
Deletion and duplication carriers of 16p11.2 show opposing and
pervasive effects on brain structure. Differences in cortical gray
matter volume were due to the preferential influence of 16p11.2
copy number variation on surface area. This finding suggests that
the mechanism underlying differences in brain volume in
16p11.2 may involve early stages of development.
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